Skip to main content
Signal8

Mulligan Seamus

SEC insider (Form 3/4/5 filer). CIK 0001536639. Director at Jazz Pharmaceuticals plc (JAZZ). 7 reported Form 4/5 transactions since Sep 2024; latest on Aug 5, 2026. Located in DUBLIN 4.

Companies Mulligan Seamus has filed insider reports for

  • Jazz Pharmaceuticals plc (JAZZ): Director
Mulligan Seamus profile photo

Mulligan Seamus

CIK: 0001536639

Transaction Breakdown

Open Market Buys (P)4 (57.1%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (14.3%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Jazz Pharmaceuticals plc logo
JAZZ

Jazz Pharmaceuticals plc

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Jazz Pharmaceuticals plc logo
    JAZZ

    Jazz Pharmaceuticals plc

    Aug 5, 2026
    Award
    Direct
    1.6K shares-
  • Jazz Pharmaceuticals plc logo
    JAZZ

    Jazz Pharmaceuticals plc

    May 28, 2026
    Exercise
    Direct
    3.4K shares at avg. $138.08$472K
  • Jazz Pharmaceuticals plc logo
    JAZZ

    Jazz Pharmaceuticals plc

    Aug 7, 2025
    Award
    Direct
    3.5K shares-
  • Jazz Pharmaceuticals plc logo
    JAZZ

    Jazz Pharmaceuticals plc

    May 12, 2025
    Purchase
    Indirect
    1.6K shares at avg. $103.00$167K
  • Jazz Pharmaceuticals plc logo
    JAZZ

    Jazz Pharmaceuticals plc

    May 9, 2025
    Purchase
    Indirect
    100 shares at avg. $99.71$10K
  • Jazz Pharmaceuticals plc logo
    JAZZ

    Jazz Pharmaceuticals plc

    May 9, 2025
    Purchase
    Indirect
    80.7K shares at avg. $98.10$7.9M
  • Jazz Pharmaceuticals plc logo
    JAZZ

    Jazz Pharmaceuticals plc

    May 9, 2025
    Purchase
    Indirect
    19.2K shares at avg. $98.91$1.9M

1-7 of 7